COMMUNIQUÉS West-GlobeNewswire

30,000 Canadian Businesses to Benefit from Teladoc Telemedicine Services
04/09/2019
Employees of small- to mid-size companies to have faster access to medical care TORONTO, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, announces today its partnership [...]
Bellerophon to Present at the H.C. Wainwright 21st Annual Global Investment Conference
04/09/2019
WARREN, N.J., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, announced today that Fabian Tenenbaum, Chief [...]
Noblegen Adds Two Top Industry Executives to its Board of Directors
04/09/2019
Former General Mills EVP of Innovation Technology and Quality, Peter Erickson, and current VP & CFO of JRSL Don Solman join Noblegen’s Board of Directors PETERBOROUGH, Ontario, Sept. 04, 2019 (GLOBE NEWSWIRE) -- [...]
Checkpoint Therapeutics to Present at September 2019 Investor Conferences
04/09/2019
NEW YORK, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage, immuno-oncology biopharmaceutical company focused on the acquisition, development and [...]
Aduro Biotech Announces First Patient Dosed in Phase 2 Study of ADU-S100 (MIW815) in Combination with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)
04/09/2019
BERKELEY, Calif., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO), a clinical-stage biopharmaceutical company focused on developing therapies targeting the Stimulator of Interferon Genes (STING) [...]
Hepion Pharmaceuticals to Present at the H. C. Wainwright 21st Annual Global Investment Conference
04/09/2019
EDISON, N.J., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a biopharmaceutical company focused on the development of therapeutic drugs for the treatment of liver disease arising from [...]
Fluidigm Launches Imaging Mass Cytometry Immuno-Oncology Panel Kits and Advanced CyTOF Software at the 2019 World Molecular Imaging Congress (WMIC)
04/09/2019
Fluidigm Showcases Immuno-Oncology Imaging Innovations at WMIC to Advance Translational and Clinical Cancer Research SOUTH SAN FRANCISCO, Calif., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), [...]
GW Pharmaceuticals to Present at the Morgan Stanley 17th Annual Global Healthcare Conference on Wednesday, September 11th, 2019
04/09/2019
CARLSBAD, Calif., Sept. 04, 2019 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc and its U.S. subsidiary Greenwich Biosciences Inc. (NASDAQ: GWPH, GW, the Company or the Group), the world leader in the science, development, [...]
Demant A/S: Update on IT infrastructure incident
04/09/2019
Demant A/S: Update on IT infrastructure incident Company announcement no 2019-09 4 September 2019 As previously announced, the Demant Group has experienced a critical incident on our internal IT infrastructure on 3 [...]
Cognition Therapeutics to Give Webcast Presentation at 3rd Annual Janney Healthcare Conference on September 9, 2019
04/09/2019
Pittsburgh, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. , a clinical stage neuroscience company focused on the protection and restoration of synaptic function in Alzheimer’s disease and other [...]
Krystal Biotech Announces Initiation of Phase 1/2 Study of KB105 in Transglutaminase-1 (“TGM1”) Deficient Autosomal Recessive Congenital Ichthyosis (“ARCI”)
04/09/2019
PITTSBURGH, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Krystal Biotech Inc. , (“Krystal”) (NASDAQ: KRYS), a gene therapy company developing medicines to treat rare skin diseases, today announced the initiation of the Phase 1/2 [...]
Chembio Diagnostics Announces $20 Million Term Loan with Perceptive Advisors
04/09/2019
MEDFORD, N.Y., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced the closing of a $20 million term [...]
Paratek Pharmaceuticals to Present at the 21st Annual H.C. Wainwright Global Investment Conference
04/09/2019
BOSTON, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics, today [...]
RETIA MEDICAL Announces Two Publications of Independent Validation Studies of its Argos Cardiac Output Monitor in off-pump coronary artery bypass surgical (OR) patients and high-risk post-cardiac surgical patients in the ICU
04/09/2019
Data show 89% (OR) and 88% (ICU) concordance (trending ability) between intermittent pulmonary artery thermodilution (PATD) and the Retia Argos cardiac output measurements VALHALLA, N.Y., Sept. 04, 2019 (GLOBE NEWSWIRE [...]
KemPharm Announces Entry into Definitive Collaboration and License Agreement for its ADHD Candidates, KP415 and KP484, with an Affiliate of Gurnet Point Capital
04/09/2019
Up to a Total of $493 Million in Upfront, Sales and Development Milestone Payments, as well as Royalties on Net Sales KemPharm Will Host a Conference Call and Live Audio Webcast with Slide Presentation Today, Wednesday [...]
Foamix Announces Issuance of New U.S. Patent Covering A Method of Treating Acne that Expires in 2037
04/09/2019
REHOVOT, Israel and BRIDGEWATER, N.J., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX) (“Foamix” or the “Company”), a clinical stage specialty pharmaceutical company focused on developing [...]
Nkarta Therapeutics Raises $114 Million in Series B Financing to Advance Multiple Programs into Clinical Trials
04/09/2019
SOUTH SAN FRANCISCO, Calif., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Nkarta Therapeutics, a privately-held biopharmaceutical company developing engineered natural killer (NK) cell therapies to fight cancer, today announced [...]
Stryker announces definitive agreement to acquire Mobius Imaging & Cardan Robotics
04/09/2019
Kalamazoo, Michigan, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) announced today a definitive agreement to acquire Mobius Imaging, LLC, a leader in point-of-care imaging technology, and its sister company, [...]
Tyme Technologies to Present at the 21st Annual Global Investment Conference Sponsored by H.C. Wainwright on September 9, 2019
04/09/2019
NEW YORK, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME) , an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced that management will present at [...]

Pages